Genome Surgery and Gene Therapy in Retinal Disorders.

about

Genome Surgery and Gene Therapy in Retinal Disorders.

Item

http://www.wikidata.org/entity/Q52429662

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Genome Surgery and Gene Therapy in Retinal Disorders.

@en

Genome Surgery and Gene Therapy in Retinal Disorders.

@nl

type

Item

label

Genome Surgery and Gene Therapy in Retinal Disorders.

@en

Genome Surgery and Gene Therapy in Retinal Disorders.

@nl

prefLabel

Genome Surgery and Gene Therapy in Retinal Disorders.

@en

Genome Surgery and Gene Therapy in Retinal Disorders.

@nl

P1476

Genome Surgery and Gene Therapy in Retinal Disorders.

@en

P2093

Lawrence Chan

http://www.w3.org/2001/XMLSchema#string

Stephen H Tsang

http://www.w3.org/2001/XMLSchema#string

Vinit B Mahajan

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

The Significance of Pneumococcal Types

Defective myosin VIIA gene responsible for Usher syndrome type 1B

Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1

Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial

Multiplex genome engineering using CRISPR/Cas systems

Ranibizumab and bevacizumab for neovascular age-related macular degeneration

Gene therapy for Leber's congenital amaurosis is safe and effective through 1.5 years after vector administration

Safety and efficacy of gene transfer for Leber's congenital amaurosis

Human RPE65 gene therapy for Leber congenital amaurosis: persistence of early visual improvements and safety at 1 year

A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity

P304

523-532

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P5008

ScienceSource

P577

2017-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2017-12-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29259518

http://www.w3.org/2001/XMLSchema#string

P921

retinal disease

biomedical investigative technique

P932

5733860

http://www.w3.org/2001/XMLSchema#string